News

A short video of capsulotomy creation with the VICTUS femtosecond laser.

Allergan and Molecular Partners AG have expanding their relationship with two new agreements for DARPin products.

The Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) and Pearson VUE partner to provide ophthalmic medical techs access to simulated exams.

Insight Software, creators of My Vision Express, has been ranked by Inc. magazine as one of the nation's fastest-growing private companies.

Patient enrollment has begun in a phase III clinical trial of a low dose of bromfenac for pain and inflammation reduction after cataract surgery.

Prevent Blindness America (PBA) has designated September as Sports Eye Safety Awareness Month.

Compared to an average of all physicians, ophthalmologists fared slightly better in a survey of physician burnout.

The 256+ channel Boston subretinal prosthesis is on track for in vivo validation of function and an FDA investigational device exemption application.

Check out this video demonstration of Swing Box, indoor golf net invented by Joe Lee, MD, ophthalmologist.

Corcoran Compliance Connection will provide real-time coding recommendations based on chart documentation in electronic health record (EHR) systems.

Prevent Blindness America (PBA) has declared August as Children's Eye Health and Safety Month to educate parents on the importance of children's healthy vision.

VSP Vision Care estimates it has spent about $150 million to provide free eye care and eyewear to 775,000 low-income, uninsured people in the past 15 years.

Alex V. Levin, MD, chief of pediatric ophthalmology and ocular genetics at Wills Eye Institute, has received a grant from Prevent Blindness America.

Bascom Palmer Eye Institute at the University of Miami is the top ophthalmology hospital for the ninth year in a row, according to U.S. News & World Report.

Phototherapeutic keratectomy (PTK) provides excellent visual outcomes in patients with irregular astigmatism and corneal opacity.

The FDA has approved once-monthly, 0.3-mg ranibizumab injection (Lucentis, Genentech) for treatment of diabetic macular edema (DME), making it the first and only drug approved by the agency for the condition. The standard of care for DME for the past 25 years has been laser surgery.

Lucentis, the 0.3-mg dose of ranibizumab injection, has been approved by the FDA for treatment of diabetic macular edema (DME).

A study, published in the Journal of Pediatric Ophthalmology and Strabismus, found exophoria to be a risk factor in 3D asthenopia (symptoms related to 3D viewing).

Bausch + Lomb (B + L) and Technolas Perfect Vision GmbH (TPV) have received 510(k) clearance from the FDA for femtosecond laser platform, Victus.

Sightpath, a provider of mobile and fixed ophthalmic surgical products, ramped up social media efforts with Facebook, Twitter, Vimeo, LinkedIn, and a blog.

Ernest Cavin, MBA, DBA, has been named president and chief executive officer of Haag-Streit USA and Reliance Medical Products, both based in Mason, OH.

A fellow at Minnesota Eye Consultants, Bryan S. Lee, MD, JD, is the first winner of the Vanguard Ophthalmology Society Scholar Award, recognizing anterior segment scholarship.

The annual Swing Fore Sight Golf Tournament, supporting the sight-saving programs of Prevent Blindness America (PBA), will coincide with Vision Expo West.

The Eye Bank Association of America has named the recipient of its annual Leonard Heise Award, Jason Woody.

Researchers have identified a protein, atypical protein kinase C (aPKC), that may help regulate the process that causes damage in diabetic retinopathy.

A study of more than 400,000 Medicare beneficiaries has found an unexpected benefit of cataract removal surgery: a 16% decrease in a specific type of fracture.

Anthony Aldave, MD, explains when cataract extraction should be done alone or with Descemet's stripping automated endothelial keratoplasty (DSAEK).

Use of imaging in clinical practice offers clinicians a number of advantages for following patients with glaucoma, perhaps most importantly the ability sometimes to detect damage before it is apparent on fundus photographs, objective rates of glaucoma progression, and the ability to predict the patients who are at high risk of functional impairment. Robert N. Weinreb, MD, talked about how imaging and clinical practice are a good fit.